Portola Pharmaceuticals Announces Proposed Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Portola Pharma (PTLA) Prices Upsized 3.13M Common Stock Offering at $48/Share
December 4, 2015 8:01 AM ESTPortola Pharma (NASDAQ: PTLA) announced the pricing of its underwritten public offering of 3,125,000 shares of its common stock at a price to the public of $48.00 per share. In addition, the underwriters of the offering have been granted a 30-day option to purchase up to an... More
Portola Pharma (PTLA) Announces 2.6M Common Stock Offering
December 3, 2015 4:35 PM ESTPortola Pharma (NASDAQ: PTLA) announced plans to offer, subject to market and other conditions, 2,600,000 shares of its common stock in an underwritten public offering. The company expects to grant the underwriters a 30-day option to purchase up to an additional 390,000 shares of common... More
